Skip to main content
Article
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial
JAMA Oncology (2020)
  • Reshma Mahtani, Baptist Health South Florida
  • Milan Radovich
  • Guanglong Jiang
  • Bradley A. Hancock
  • Christopher Chitambar
  • Rita Nanda
  • Carla Falkson
  • Filipa C. Lynce
  • Christopher Gallagher
  • Claudine Isaacs, Georgetown University
  • Marcelo Blaya, East Jefferson General Hospital
  • Elisavet Paplomata
  • Radhika Walling
  • Karen Daily
  • Michael Thompson
  • Robert Graham
  • Maureen E. Cooper
  • Dean C. Pavlick
  • Lee A. Albacker
  • Jeffrey Gregg
  • Jeffrey P. Solzak
  • Yu-Hsiang Chen
  • Casey L. Bales
  • Erica Cantor
  • Fei Shen
  • Anna Maria V. Storniolo
  • Sunil Badve, Indiana University
  • Tarah J. Ballinger, Indiana University
  • Chun-Li Chang
  • Yuan Zhong
  • Cagri Savran
  • Kathy Miller
  • Bryan Schneider
Publication Date
2020
Citation Information
Reshma Mahtani, Milan Radovich, Guanglong Jiang, Bradley A. Hancock, et al.. "Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial" JAMA Oncology Vol. 6 Iss. 9 (2020) p. 1410 - 1415
Available at: http://works.bepress.com/reshma-mahtani/93/